In vitro activity of LY146032 against gram-positive bacteria
- 1 February 1988
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 9 (2) , 79-85
- https://doi.org/10.1016/0732-8893(88)90100-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studiesAntimicrobial Agents and Chemotherapy, 1987
- Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendationsAntimicrobial Agents and Chemotherapy, 1987
- Effect of calcium on in vitro activity of LY146032 against Clostridium difficileAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteriaAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocciAntimicrobial Agents and Chemotherapy, 1987
- Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycinAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of LY146032 against staphylococci, streptococci, and enterococciAntimicrobial Agents and Chemotherapy, 1986
- In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibioticAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibioticAntimicrobial Agents and Chemotherapy, 1985